Welcome to Our Company

Send Inquiry

Request To Call Back

DENOSUREL 120 MG

Get a Price/Quote

DENOSUREL 120 MG Specification

Molecular Formula
C32H44N8O8S2

Origin of Medicine
India

Dosage
120 mg

Dosage Form
Injection

Pacakaging (Quantity Per Box)
Single Vial per Box

Salt Composition
Denosumab 120 mg

CAS No
184475-35-2

Usage
Used for the treatment of Bone Metastases and Osteoporosis

Indication
To treat bone loss, osteoporosis, metastatic bone disease, and certain cancers

Appearance
Lyophilized Powder

Expiration Date
24 months from manufacturing date

Storage
Store below 30C, protected from light and moisture

Medicine Type
Pharmaceutical Injection

Assay
>98%

Grade
Medicine Grade

Therapeutic Class
Monoclonal Antibody

Side Effects
May cause hypocalcemia, infections, or dermatological reactions

Prescription/Non prescription
Prescription

Box Contains
1 vial + package insert

Container Type
Glass Vial

Warning
For healthcare professional use only.

Reconstitution Required
No, ready-to-use formulation

Administration Route
Subcutaneous Injection

Shelf Life
24 months

Strength
120 mg

DENOSUREL 120 MG Trade Information

Payment Terms
Cash Advance (CA)

Main Domestic Market
All India

About DENOSUREL 120 MG

Denosurel 120mg Injection is a medicine used in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It makes the bones strong and reduce the risk of fractures.

Denosurel 120mg Injection is given by a healthcare professional and should not be self-administered. You should use it regularly and at the same time each day to get maximum benefit from it. Continue using it as recommended by your doctor and complete the dose even if you feel better. To make it more effective, take adequate amount of calcium and vitamin D supplements while on treatment with this medicine.

How DENOSUREL Works

DENOSUREL 120 MG, with Denosumab as its active ingredient, acts as a monoclonal antibody that interferes with the RANK ligand pathway. This action effectively curtails bone resorption, helping maintain bone density and strength. The medication is particularly valuable for patients battling bone metastases, osteoporosis, or cancer-related bone loss, offering targeted support to minimize skeletal complications.

Simple and Ready-to-Use

This medicine is supplied as a lyophilized powder in a glass vial and is designed for direct subcutaneous administration without the need for reconstitution. Its ready-to-use formulation ensures convenience and minimizes preparation errors, making it ideal for clinical settings focused on safety and efficiency.

Quality, Storage, and Safety

Manufactured in India to medicine-grade standards, DENOSUREL surpasses 98% assay purity. It is essential to store the product below 30C, shielding it from light and moisture, to retain efficacy throughout its 24-month shelf life. Detailed product information is included in the packaging to guide healthcare professionals in optimal usage.

FAQ's of DENOSUREL 120 MG:

Q: How should DENOSUREL 120 MG injection be administered?

A: DENOSUREL 120 MG is administered as a subcutaneous injection, typically into the upper arm, thigh, or abdomen, by a qualified healthcare professional. No reconstitution is required as the product comes ready-to-use.

Q: What conditions is DENOSUREL 120 MG indicated for?

A: This medication is used to treat bone loss, osteoporosis, metastatic bone disease, and bone complications related to certain cancers, as outlined in the package insert.

Q: When is DENOSUREL 120 MG prescribed and who should use it?

A: DENOSUREL 120 MG is prescribed based on a physician's assessment, particularly for adults who require bone protection due to osteoporosis, cancer with bone metastases, or treatment-induced bone loss.

Q: Where should DENOSUREL 120 MG be stored before use?

A: Store DENOSUREL below 30C in its original glass vial, protected from light and moisture. Always keep it out of reach of children and only under professional supervision.

Q: What is the benefit of using DENOSUREL 120 MG over other bone-modifying agents?

A: DENOSUREL's monoclonal antibody mechanism offers selective inhibitory activity against bone resorption, resulting in targeted bone protection and lower risk of fractures, especially in cancer and osteoporosis patients.

Q: Are there any side effects associated with DENOSUREL 120 MG?

A: Common side effects may include hypocalcemia (low blood calcium), increased susceptibility to infections, or dermatological reactions. Monitoring and supportive care are recommended under healthcare supervision.

Q: Is any preparation or mixing required before administering DENOSUREL 120 MG?

A: No preparation or reconstitution is needed; the formulation is supplied as a ready-to-use lyophilized powder, simplifying the administration process for healthcare providers.

Tell us about your requirement